Medicare Part D drug Data year 2024 Brand name Source: CMS Part D Prescribers

Humira(Cf)

Adalimumab

Open in the dashboard

Part D claims

30,728

Prescriptions dispensed, refills included

Drug cost

$254,685,325

Paid at the pharmacy, in all

Prescribers

1,688

With 11 or more claims of it

In 2024, Medicare Part D recorded 30,728 claims for Humira(Cf) (adalimumab) from 1,688 prescribers, at a total drug cost of $254.7 million paid at the pharmacy by Medicare, patients and others.

Where it is prescribed

By the prescriber's state · 52 states and territories
Part D claims for Humira(Cf) by the state of the prescriber, 2024
State Relative to the most Prescribers Claims Drug cost
CA 128 2,393 $18,530,212
TX 125 2,316 $19,843,544
NY 111 2,278 $19,080,812
FL 112 1,930 $15,742,389
MI 76 1,503 $12,232,136
PR 40 1,288 $9,094,673
PA 67 1,178 $10,660,787
OH 69 1,091 $9,833,162
MA 52 1,089 $9,184,970
NC 63 1,072 $9,361,223
IL 55 824 $6,952,308
GA 45 812 $6,707,573
MO 46 766 $7,268,859
TN 44 758 $6,423,025
CO 38 743 $6,106,298
The other 37 states and territories
State Prescribers Claims Drug cost
AZ 33 730 $6,239,294
NJ 36 679 $5,428,222
IN 36 652 $5,070,231
WI 31 610 $5,016,133
WA 35 571 $5,083,230
OR 26 544 $4,121,259
LA 29 525 $4,432,863
KY 30 472 $3,736,475
OK 25 441 $3,773,875
IA 22 407 $3,247,254
SC 25 396 $3,686,372
VA 25 380 $3,148,861
AL 21 351 $2,720,579
MD 22 351 $2,847,685
CT 21 318 $2,892,605
MN 21 315 $2,816,482
AR 14 273 $2,038,897
MS 17 263 $2,110,513
WV 12 249 $1,965,107
UT 15 224 $1,568,927
ME 11 222 $1,698,228
MT 10 218 $1,720,112
NV 11 188 $1,398,653
ID 11 164 $1,442,199
NE 11 162 $1,292,508
NH 11 157 $1,262,421
NM 10 141 $1,082,709
KS 9 125 $924,436
VT 8 106 $963,303
RI 6 96 $758,630
AK 4 83 $1,022,654
ND 6 71 $689,346
SD 5 62 $416,026
DE 3 54 $433,552
DC 2 39 $305,221
HI 2 35 $225,446
WY 1 13 $83,046

The state is where the prescriber practices, not where the patient lives. Totals are Medicare Part D claims only.

Which specialties prescribe it

Top 15 of 19
Part D claims for Humira(Cf) by prescriber specialty, 2024
Specialty Relative to the most Prescribers Claims Drug cost
Rheumatology 960 19,008 $156,475,514
Internal Medicine 138 2,620 $20,471,757
Nurse Practitioner 156 2,565 $21,041,898
Physician Assistant 122 2,011 $18,016,290
Gastroenterology 148 1,958 $17,851,744
Dermatology 97 1,336 $10,869,534
Family Practice 37 513 $4,367,529
Allergy/ Immunology 5 322 $2,196,447
Ophthalmology 8 163 $1,454,488
General Practice 5 65 $529,145
Pulmonary Disease 2 25 $277,043
Emergency Medicine 2 25 $174,478
Obstetrics & Gynecology 1 25 $191,701
Student in an Organized Health Care Education/Training Program 2 23 $225,049
Physical Medicine and Rehabilitation 1 18 $125,728

Specialty is the one printed on each prescriber's Medicare claims.

Largest prescribers

First 5 of 100 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Michael Babilonia Roman Internal Medicine PR 265 $1,830,745 None on record
Roger Wang Allergy/ Immunology CA 212 $1,338,312 None on record
Elvin Garcia Rheumatology TX 194 $1,447,880 None on record
Ya Ju Chang Rheumatology NY 176 $1,236,743 None on record
Carl Restivo Rheumatology NJ 149 $1,089,783 None on record

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See more in the dashboard: 25 with a free account, all 100 with Patron

Industry payments naming this drug

From CMS Open Payments

Open Payments names products as manufacturers reported them, and CMS does not link them to Part D drugs, so this match is by name and ours. The two records are separate: they do not show that a payment affected a prescription.

Other names for adalimumab

What this means

Medicare Part D is the part of Medicare that covers prescription drugs dispensed at a pharmacy. Each year CMS publishes, for every prescriber and drug, how many claims were dispensed and what they cost. This page adds those up for one drug.

A claim is one prescription filled, refills included. Drug cost is the total paid at the pharmacy by Medicare, the patient and anyone else; it is not money to the prescriber. CMS leaves out any prescriber with fewer than 11 claims of a drug, so the prescriber count is a floor and a missing prescriber does not mean none.

Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy. It does not include drugs given in a clinic or hospital, patients with other insurance, or the most recent year, which Medicare publishes about two years behind.

Provenance

Source: CMS Medicare Part D Prescribers by Provider and Drug · data year 2024

We reproduce what CMS published. We do not verify, edit or correct the underlying records.

A prescription record is not evidence of wrongdoing, and nothing here is medical advice. Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency.

How to dispute or correct a record